Recurrent amiodarone pulmonary toxicity.


Amiodarone, a widely used antiarrhythmic drug, is associated with pulmonary toxicity, with an estimated mortality of 1% to 33%. Standard treatment for amiodarone pulmonary toxicity (APT) has been discontinuance of the drug and steroid therapy. We report a case of APT that recurred after withdrawal of steroids and failed to respond to reinstatement of… (More)


Cite this paper

@article{Chendrasekhar1996RecurrentAP, title={Recurrent amiodarone pulmonary toxicity.}, author={Akella Chendrasekhar and Roderick A. Barke and Pablo Druck}, journal={Southern medical journal}, year={1996}, volume={89 1}, pages={85-6} }